Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1057 | 963 | 1207 | 1000 | 1486 | 1788 |
Fund Return | 5.72% | -3.74% | 20.73% | 0.01% | 8.25% | 5.98% |
Place in category | 512 | 733 | 482 | 228 | 143 | 153 |
% in Category | 52 | 74 | 47 | 41 | 28 | 54 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
JPI Global Income Fund A acc USD he | 17.7B | 9.76 | 2.45 | 4.17 | ||
JPI Global Income Fund A div USD he | 17.7B | 9.78 | 2.47 | 4.18 | ||
JPI Global Income Fund A mth USD he | 17.7B | 9.75 | 2.44 | 4.16 | ||
JPI Global Income Fund C acc USD he | 17.7B | 10.32 | 3.13 | 4.86 | ||
JPI Global Income Fund C dist USD h | 17.7B | 10.31 | 3.12 | 4.85 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
World Healthscience Fund C2u | 382.06M | 7.65 | 1.73 | 6.66 | ||
World Healthscience Fund D2u | 1.29B | 9.47 | 3.79 | 8.82 | ||
World Healthscience Fund X2 USD | 45.89M | 10.37 | 4.81 | 9.91 | ||
World Healthscience Fund A2 | 6.67B | 8.78 | 3.01 | 8.01 | ||
World Healthscience Fund E2 | 2.18B | 8.32 | 2.49 | 7.47 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Eli Lilly | US5324571083 | 8.85 | 749.92 | -0.46% | |
UnitedHealth | US91324P1021 | 7.98 | 597.49 | -0.50% | |
Novo Nordisk B | DK0062498333 | 5.92 | 721.8 | -2.21% | |
AbbVie | US00287Y1091 | 5.72 | 171.73 | +2.37% | |
Thermo Fisher Scientific | US8835561023 | 4.74 | 516.10 | +0.64% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Sell | Strong Sell | Neutral |
Technical Indicators | Strong Sell | Strong Sell | Sell |
Summary | Strong Sell | Strong Sell | Neutral |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review